Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • VANDA PHARMACEUTICALS INC Financial Overview

  • Income Statement: VNDA

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 0.00 0.00 0.00 N/A%
    Gross Profit -530,805.00 -571,586.00 40,781.00 -7.68%
    Net Income Before Extra Items/Preferred Div -51.06 M -74.07 M 23.01 M -45.05%
    Operating Income -52.85 M -80.04 M 27.19 M -51.46%
  • Cash Flow: VNDA

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 0.00 111.40 M -111.40 M -∞ T%
    Net Cash Flow - Investing -43.09 M 48.76 M -91.85 M 213.16%
    Net Cash Flow/Operating Activities -45.96 M -51.64 M 5.69 M -12.37%
  • Balance Sheet: VNDA

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 49.93 M 96.86 M -46.93 M -93.98%
    Total Liabilities 3.91 M 13.13 M -9.22 M -235.55%
    Shareholders Equity 46.02 M 83.73 M -37.71 M -81.94%
  • Key Ratios / Statistics: VNDA

    • Valuation

      Price/Earnings (TTM) -0.26
      Price/Sales (TTM)
      Price/Book (MRQ) 10.76
      Price/Cash Flow (TTM) -11.91
    • Profitability

      Gross Margin -1,008.62
      Operating Margin -28,041.19
      Profit Margin -27,881.95
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 13.82
      Current Ratio (MRQ) 2.99
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -78.88
      Return on Assets (TTM) -71.56
      Return on Investments (TTM) -78.71